Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-30 Shaff Eric D. CFO and EVP Sale −4,533 $29.54 $134K 0
2016-06-30 Shaff Eric D. CFO and EVP Exercise or conversion · Stock Option (right to buy) −4,533 233,454
2016-06-28 Shaff Eric D. CFO and EVP Exercise or conversion +1,667 $7.79 $13K 1,667
2016-06-28 Shaff Eric D. CFO and EVP Sale −1,667 $28.85 $48K 0
2016-06-28 Shaff Eric D. CFO and EVP Exercise or conversion · Stock Option (right to buy) −1,667 237,987
2016-06-27 Aunins John G. Chief Technology Officer & EVP Sale −9,390 $27.23 $256K 32,655
2016-06-27 Shaff Eric D. CFO and EVP Exercise or conversion +3,334 $7.79 $26K 3,334
2016-06-27 Shaff Eric D. CFO and EVP Sale −3,334 $28.00 $93K 0
2016-06-27 Shaff Eric D. CFO and EVP Exercise or conversion · Stock Option (right to buy) −3,334 239,654
2016-06-15 Kim Lorence H. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2016-06-15 Graves Kurt Director Grant or award · Stock Option (right to buy) +15,000 15,000
2016-06-15 Kender Richard N Director Grant or award · Stock Option (right to buy) +15,000 15,000
2016-06-15 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +15,000 15,000
2016-06-15 AFEYAN NOUBAR Director Grant or award · Stock Option (right to buy) +15,000 15,000
2016-06-15 HUTT PETER BARTON Director Grant or award · Stock Option (right to buy) +15,000 15,000
2016-06-02 Pomerantz Roger President and CEO Exercise or conversion +74,049 $0.71 $53K 257,741
2016-06-02 Pomerantz Roger President and CEO Sale −6,583 $31.62 $208K 251,158
2016-06-02 Pomerantz Roger President and CEO Sale −47,159 $32.34 $1.5M 203,999
2016-06-02 Pomerantz Roger President and CEO Sale −20,307 $33.22 $675K 183,692
2016-06-02 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −74,049 1,217,286

Page 33 of 34 · 662 trades